Brophy Michael Burkes sold $314K of NTRA
Brophy Michael Burkes (CHIEF FINANCIAL OFFICER) sold 795 shares of Natera, Inc. (NTRA) at an average of $394.97 ($388.03–$400.29, $0.31M total) across 3 trades over 2026-11-02 to 2026-11-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data for investors but is unlikely to move the stock materially.
Market read
A small insider sale by the CFO, reported via a Form 4, offers limited trading relevance.
What to watch
Potential tax planning or liquidity needs unrelated to company performance.
Background
Form 4 filings disclose insider transactions; a CFO sale is a standard disclosure.
Ticker impact
CFO Brophy Michael Burkes sold 795 shares for $313,998 via a 10b5-1 plan, reducing his stake to 45,779 shares.
likely slight downward pressure as the market prices the CFO's sale.
The transaction size (~$0.3M) is small relative to market cap, but CFO sales are watched by investors and can trigger short-term price dips.
Market effects
Minimal impact on the broader biotech sector.
No significant regional effect.
Limited to investors tracking Natera.
Counterpoint
The sale could be routine and not indicative of any fundamental concerns.
Key entities
- personBrophy Michael Burkes
Chief Financial Officer of Natera, Inc.
- companyNatera, Inc.
Genomics testing company listed on NASDAQ.



